Antidepressants fluoxetine and amitriptyline induce alterations in intestinal microbiota and gut microbiome function in rats exposed to chronic unpredictable mild stress
Authors:
Open Access
- 18 February 2021
- journal article
- research article
- Published by Springer Nature in Translational Psychiatry
- Vol. 11 (1) , 1-16
Abstract
Antidepressant medications are known to modulate the central nervous system, and gut microbiota can play a role in depression via microbiota–gut–brain axis. But the impact of antidepressants on gut microbiota function and composition remains poorly understood. Thus this study assessed the effect of serotonin reuptake inhibitor antidepressant fluoxetine (Flu) and tricyclic antidepressant amitriptyline (Ami) administration on gut microbiota composition, diversity, and species abundance, along with microbial function in a chronic unpredictable mild stress (CUMS)-induced depression rat model. Oral administration of Ami and Flu significantly altered the overall gut microbiota profile of CUMS-induced rats, as assessed using the permutational multivariate analysis of variance test. At the phylum level, 6-week of antidepressant treatment led to a decreased Firmicutes/Bacteroidetes ratio due to an enhanced Bacteroidetes and reduced Firmicutes relative abundance. Flu was more potent than Ami at altering the Firmicutes and Bacteroidetes levels in the CUMS rats. At the family level, both antidepressants significantly increased the abundance of Porphyromonadaceae. However, an increased Bacteroidaceae level was significantly associated with Ami, not Flu treatment. Furthermore, at the genus level, an increase in the relative abundance of Parabacteroides, Butyricimonas, and Alistipes was observed following Ami and Flu treatment. Subsequent metagenomics and bioinformatics analysis further indicated that Ami and Flu likely also modulated metabolic pathways, such as those involved in carbohydrate metabolism, membrane transport, and signal transduction. Additionally, both antidepressants affected antibiotic resistome, such as for aminoglycoside (aph3iiiA), multidrug (mdtK, mdtP, mdtH, mdtG, acrA), and tetracycline (tetM) resistance in CUMS rats. These data clearly illustrated the direct impact of oral administration of Flu and Ami on the gut microbiome, thus set up the foundation to reveal more insights on the therapeutic function of the antidepressants and their overall contribution to host health.Keywords
This publication has 82 references indexed in Scilit:
- Gastrointestinal Microbiome Signatures of Pediatric Patients With Irritable Bowel SyndromeGastroenterology, 2011
- The GABAergic deficit hypothesis of major depressive disorderMolecular Psychiatry, 2010
- QIIME allows analysis of high-throughput community sequencing dataNature Methods, 2010
- A Meta-Analysis of Cytokines in Major DepressionBiological Psychiatry, 2010
- Major Depressive DisorderNew England Journal of Medicine, 2008
- Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseasesProceedings of the National Academy of Sciences, 2007
- Human gut microbes associated with obesityNature, 2006
- Obesity alters gut microbial ecologyProceedings of the National Academy of Sciences, 2005
- The immunostimulating and antimicrobial properties of lithium and antidepressantsJournal of Infection, 2004
- Antimicrobial activity of psychotropic drugsInternational Journal of Antimicrobial Agents, 2000